 This is a pilot, observational, single-center, single-visit, outpatient study. Approximately 30 to 50 subjects will participate in the study during an approximately 8 to 12 week study enrollment period. Eligible subjects who meet the inclusionexclusion criteria for this study will be invited to participate. The following documentation and information will be provided by subjects: 